Dr. Carla Rodriguez-Watson is the Director of Research at the Reagan-Udall Foundation for the FDA. The Foundation is an independent non-profit established by Congress to supportFDA’smission to modernize product development, accelerate innovation, and enhance product safety. Research programs cultivate and leverage public-private partnership and network studies to accelerate and improve real-world evidence generation for risk/benefit assessment of medical products.
Dr. Rodriguez-Watson, an infectious disease epidemiologist by training, has more than 23years of experience with research using real-world data to examine health outcomes and comparative effectiveness, and in developing and evaluating public health surveillance systems. Her experience spans from Kaiser Permanente Research and the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS), where she focused on the use of health care transaction data (from claims and the EHR) in epidemiologic studies of HIV, viral hepatitis, liver and kidney disease; to the health departments of New York City, San Francisco, and Seattle & King County where she focused on developing and testing the accuracy of syndromic surveillance systems to identify outbreaks of specific disease.
Dr. Rodriguez-Watson earned her PhD in Epidemiology from the University of Washington School of Public Health; her MPH from Columbia University Mailman School of Public Health; and her BA from Rutgers University.